학술논문
Which dose of apixaban is suitable for Asian patients with atrial fibrillation who have a serum creatinine
Document Type
article
Author
Source
International Journal of Cardiology: Heart & Vasculature, Vol 50, Iss , Pp 101333- (2024)
Subject
Language
English
ISSN
2352-9067
Abstract
Introduction: Reduced-dose (Low-dose [LD]) apixaban is recommended in patients with atrial fibrillation (AF) who fulfill 2 of 3 criteria: age ≥ 80 years, body weight ≤ 60 kg, and a serum creatinine (sCr) ≥ 1.5 mg/dl. However, the suitable (appropriate) dose for Asian patients who have a sCr